Alnylam Pharmaceuticals (ALNY) Technical (Analysis) Reports Alnylam Pharmaceuticals ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com
Complete & easy to understand technical analysis of Alnylam Pharmaceuticals (ALNY)
Technical Analysis Report for USA stock ALNY Alnylam Pharmaceuticals. Dated: 03 Jun 2026 Updated Daily. Stock trades under Health Care Deals in Major Pharmaceuticals in USA stock exchange
If you are looking for Tomorrow's Movement Predictions for USA stock ALNY Alnylam Pharmaceuticals then click here. or read Experts views on Alnylam Pharmaceuticals or Forecast & share price targets of Alnylam Pharmaceuticals
Alnylam Pharmaceuticals Opened at 284.48 and Closed at: 292.58, which is 2.21% of previous session's close. It moved within a range of 283.10 and 293.16
The session was a Bullish session with an average volume of 988500, which is -5.47% of previous session's volumes.
- Even though the stock has shown an up move, but the short term trend of the stock remains negative and in a downtrend.
- Even though the stock has shown an up move, but the mid term trend of the stock remains negative and in a downtrend.
- Even though the stock has shown an up move, but the long term trend of the stock remains negative and in a downtrend.
A Golden cross was found 4 days back on short term averages
Support for tomorrow is 287.84 and resistance for tomorrow is 297.9
These support and resistance points are valid for the first 5-15 minutes charts
Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.
Support for tomorrow's hourly charts is 286.07, 279.55 resistance for tomorrow's hourly charts is 296.13, 299.67
10 Day SMA for Alnylam Pharmaceuticals (ALNY) is 296.89 and stock is trading below these levels. This is not a good sign for its short term trend
20 Day SMA for Alnylam Pharmaceuticals (ALNY) is 294.61 and the stock is trading below these levels. This is not a good sign for its mid term trend
50 Day SMA for Alnylam Pharmaceuticals (ALNY) is 307.72 and the stock is trading below these levels. This is not a good sign for its mid to long term trend
100 Day SMA is 321.73 and the stock is trading below these levels. This is not a good sign for its long term trend
200 Day SMA Alnylam Pharmaceuticals is 383.35 and stock is trading below these levels. This is not a good sign for its long term trend
20 DMA of Alnylam Pharmaceuticals is at 294.61 and 200 DMA is at 383.35, while 50 DMA and 100 DMA are at 307.72 and 321.73 respectively
Alnylam Pharmaceuticals (ALNY) moving average of 20 SMA is at 294.61 and 20 EMA is at 296.9
| Date | Closing Price | 20 SMA | 20 EMA |
| 03 Wed Jun | 292.58 | 294.61 | 296.9 |
| 02 Tue Jun | 286.12 | 295.13 | 297.35 |
| 01 Mon Jun | 295.63 | 295.88 | 298.53 |
| 29 Fri May | 301.98 | 296 | 298.83 |
| 28 Thu May | 305.06 | 295.7 | 298.5 |
| 27 Wed May | 295.63 | 295.93 | 297.81 |
Alnylam Pharmaceuticals (ALNY) moving average of 50 SMA is at 307.72 and 50 EMA is at 306.67
| Date | Closing Price | 50 SMA | 50 EMA |
| 03 Wed Jun | 292.58 | 307.72 | 306.67 |
| 02 Tue Jun | 286.12 | 308.02 | 307.24 |
| 01 Mon Jun | 295.63 | 308.44 | 308.1 |
| 29 Fri May | 301.98 | 308.77 | 308.61 |
| 28 Thu May | 305.06 | 308.95 | 308.88 |
| 27 Wed May | 295.63 | 309.26 | 309.04 |
Alnylam Pharmaceuticals (ALNY) moving average of 100 SMA is at 321.73 and 100 EMA is at 326.05
| Date | Closing Price | 100 SMA | 100 EMA |
| 03 Wed Jun | 292.58 | 321.73 | 326.05 |
| 02 Tue Jun | 286.12 | 322.8 | 326.73 |
| 01 Mon Jun | 295.63 | 324.16 | 327.55 |
| 29 Fri May | 301.98 | 325.27 | 328.19 |
| 28 Thu May | 305.06 | 326.23 | 328.72 |
| 27 Wed May | 295.63 | 327.18 | 329.2 |
Alnylam Pharmaceuticals (ALNY) moving average of 200 SMA is at 383.35 and 200 EMA is at 340.04
| Date | Closing Price | 200 SMA | 200 EMA |
| 03 Wed Jun | 292.58 | 383.35 | 340.04 |
| 02 Tue Jun | 286.12 | 384.17 | 340.52 |
| 01 Mon Jun | 295.63 | 384.99 | 341.07 |
| 29 Fri May | 301.98 | 385.72 | 341.53 |
| 28 Thu May | 305.06 | 386.37 | 341.93 |
| 27 Wed May | 295.63 | 387 | 342.3 |
Alnylam Pharmaceuticals has performed better than Brookdale Senior in short term. Holding Alnylam Pharmaceuticals could be a better choice for now!
Alnylam Pharmaceuticals has performed better than Astrazeneca Plc in short term. Holding Alnylam Pharmaceuticals could be a better choice for now!
Avanos Medical has performed better than Alnylam Pharmaceuticals in short term. You could have earned much better returns by investing in Avanos Medical, about 4.49% more returns!
Alnylam Pharmaceuticals has performed better than Zymeworks Inc in short term. Holding Alnylam Pharmaceuticals could be a better choice for now!
Xoma Corporation has performed better than Alnylam Pharmaceuticals in short term. You could have earned much better returns by investing in Xoma Corporation, about 3.68% more returns!
Alnylam Pharmaceuticals has performed better than Vericel Corporation in short term. Holding Alnylam Pharmaceuticals could be a better choice for now!
Urogen Pharma has performed better than Alnylam Pharmaceuticals in short term. You could have earned much better returns by investing in Urogen Pharma, about 4.77% more returns!
Alnylam Pharmaceuticals has performed better than Tactile Systems in short term. Holding Alnylam Pharmaceuticals could be a better choice for now!
National Research has performed better than Alnylam Pharmaceuticals in short term. You could have earned much better returns by investing in National Research, about 10.05% more returns!
Moderna Inc has performed better than Alnylam Pharmaceuticals in short term. You could have earned much better returns by investing in Moderna Inc, about 3.95% more returns!
Alnylam Pharmaceuticals has performed better than Mesoblast in short term. Holding Alnylam Pharmaceuticals could be a better choice for now!
Kalvista Pharmaceuticals has performed better than Alnylam Pharmaceuticals in short term. You could have earned much better returns by investing in Kalvista Pharmaceuticals, about 4.3% more returns!
Alnylam Pharmaceuticals has performed better than Inmune Bio in short term. Holding Alnylam Pharmaceuticals could be a better choice for now!
Alnylam Pharmaceuticals has performed better than Harrow Health in short term. Holding Alnylam Pharmaceuticals could be a better choice for now!
Eyegate Pharmaceuticals has performed better than Alnylam Pharmaceuticals in short term. You could have earned much better returns by investing in Eyegate Pharmaceuticals, about 2.9% more returns!
Establishment Labs has performed better than Alnylam Pharmaceuticals in short term. You could have earned much better returns by investing in Establishment Labs, about 0.58% more returns!
Alnylam Pharmaceuticals has performed better than Denali Therapeutics in short term. Holding Alnylam Pharmaceuticals could be a better choice for now!
Alnylam Pharmaceuticals has performed better than Cytokinetics Incorporated in short term. Holding Alnylam Pharmaceuticals could be a better choice for now!
Assertio Therapeutics has performed better than Alnylam Pharmaceuticals in short term. You could have earned much better returns by investing in Assertio Therapeutics, about 9.16% more returns!
Alnylam Pharmaceuticals Technical analysis of indicators
Price action analysis of Alnylam Pharmaceuticals (ALNY) based on a short term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
ADX buy sell signal for Alnylam Pharmaceuticals stock for short term is SELL. Signal strength is Strong and stock is gaining momentum.
MACD generated a BUY signal for Alnylam Pharmaceuticals in short term but the buy signal is initial and weak.
Alnylam Pharmaceuticals Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are getting stronger in this stock.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be moving up
CCI has generated a buy signal for Alnylam Pharmaceuticals in short term but BUY signal is weak.
RSI is generating a SELL signal in short term but selling is losing momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Alnylam Pharmaceuticals is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 297.42 and Alnylam Pharmaceuticals ALNY stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Alnylam Pharmaceuticals ALNY stock. Volume based technical analysis of Alnylam Pharmaceuticals ALNY stock is negative.
Alnylam Pharmaceuticals Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Tomorrow's Predictions
You should also read Tomorrow's Movement Predictions for USA stock ALNY Alnylam Pharmaceuticals These predictions are based on various factors, are easy to understand, and upto 75% accurate!
And ALNY Experts View which covers a lot of information including buying and selling signals
ALNY future forecast & share price targets
You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Alnylam Pharmaceuticals or View Candle Stick Charts here
Quick Charts: Renko Point & Figure Just IntraDay All Indicators Weekly Monthly All in One Eagle View MACD & ADX
Videos related to: Alnylam Pharmaceuticals (ALNY) Technical (Analysis) Reports Alnylam Pharmaceuticals ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com
Hindi Basics How To Trade In FnO Futures Options Stock Market
Hindi Video The Truth Of Stock Markets That Everyone Is Hiding From You
- USA Screeners
- USA Daily Screener
- USA Weekly Screener
- USA Monthly Screener
- Support & Resistance
- USA Shares Near Support
- USA Shares Near Resistance


